Intuitive Surgical Inc. reported second-quarter earnings of $2.80 per share on Thursday, surpassing analysts' expectations of $2.50 by 12%. The company's revenue reached $2.89 billion, exceeding the consensus estimate of $2.82 billion, according to Benzinga Pro data.
Key Details
CEO Dave Rosa commented on the results, stating,
We are pleased with company performance this quarter, which reflects the strength of our portfolio — from da Vinci and Ion to our growing digital solutions.
Despite the positive earnings report, Intuitive Surgical's stock fell 8.53% to $368.99 in extended trading following the announcement.
Background
The decline in stock price comes as investors reacted to the earnings report, which some analysts viewed as not enough to justify the current valuation of the company. The stock's performance may indicate concerns about future growth and market conditions.
The decline in Intuitive Surgical's stock could affect investor sentiment in the medical technology sector, particularly for companies with similar product lines. The drop may lead to increased scrutiny of future earnings and growth projections in the industry.
Investors will watch for the company's guidance on upcoming quarters and any strategic initiatives that may be discussed in the next earnings call.